Your browser doesn't support javascript.
loading
Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.
Kwon, Minsuk; An, Minae; Klempner, Samuel J; Lee, Hyuk; Kim, Kyoung-Mee; Sa, Jason K; Cho, Hee Jin; Hong, Jung Yong; Lee, Taehyang; Min, Yang Won; Kim, Tae Jun; Min, Byung-Hoon; Park, Woong-Yang; Kang, Won Ki; Kim, Kyu-Tae; Kim, Seung Tae; Lee, Jeeyun.
Afiliação
  • Kwon M; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • An M; Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Korea.
  • Klempner SJ; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Lee H; Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim KM; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Sa JK; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Korea.
  • Cho HJ; Innovative Institute for Precision Medicine, Samsung Medical Center, Seoul, Korea.
  • Hong JY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee T; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Min YW; Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim TJ; Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Min BH; Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park WY; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim KT; Department of Physiology, Ajou University School of Medicine, Suwon, Korea. jyunlee@skku.edu shty1@skku.edu kimqtae@ajou.ac.kr.
  • Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jyunlee@skku.edu shty1@skku.edu kimqtae@ajou.ac.kr.
  • Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jyunlee@skku.edu shty1@skku.edu kimqtae@ajou.ac.kr.
Cancer Discov ; 11(9): 2168-2185, 2021 09.
Article em En | MEDLINE | ID: mdl-33846173

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Biomarcadores Tumorais / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Biomarcadores Tumorais / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article